Concepts (138)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Asthma | 13 | 2021 | 4383 | 0.94 | Why? |
| Helminthiasis | 2 | 2017 | 78 | 0.80 | Why? |
| Therapy with Helminths | 1 | 2017 | 2 | 0.73 | Why? |
| Antigens, Helminth | 1 | 2017 | 54 | 0.70 | Why? |
| Tiotropium Bromide | 1 | 2018 | 46 | 0.70 | Why? |
| Rhinitis, Allergic | 6 | 2020 | 704 | 0.68 | Why? |
| Parasitic Diseases | 1 | 2017 | 84 | 0.65 | Why? |
| Allergy and Immunology | 1 | 2017 | 240 | 0.53 | Why? |
| Hypersensitivity | 3 | 2021 | 1137 | 0.52 | Why? |
| TRPA1 Cation Channel | 2 | 2021 | 82 | 0.42 | Why? |
| Histamine H1 Antagonists | 2 | 2019 | 79 | 0.35 | Why? |
| Adrenal Cortex Hormones | 3 | 2021 | 6537 | 0.33 | Why? |
| NF-E2-Related Factor 2 | 2 | 2021 | 373 | 0.33 | Why? |
| TRPV Cation Channels | 1 | 2021 | 88 | 0.20 | Why? |
| Sublingual Immunotherapy | 1 | 2020 | 88 | 0.20 | Why? |
| Spices | 1 | 2020 | 130 | 0.20 | Why? |
| Scopolamine Derivatives | 1 | 2018 | 10 | 0.18 | Why? |
| Dental Pulp Necrosis | 1 | 2017 | 2 | 0.18 | Why? |
| Periapical Periodontitis | 1 | 2017 | 4 | 0.18 | Why? |
| Cryotherapy | 1 | 2017 | 31 | 0.18 | Why? |
| Interleukin-1 Receptor Accessory Protein | 1 | 2017 | 4 | 0.17 | Why? |
| Immunoglobulin E | 3 | 2020 | 557 | 0.17 | Why? |
| Helminths | 1 | 2017 | 60 | 0.17 | Why? |
| Bronchodilator Agents | 2 | 2019 | 444 | 0.15 | Why? |
| Transforming Growth Factor beta1 | 1 | 2017 | 204 | 0.15 | Why? |
| Anti-Allergic Agents | 1 | 2017 | 167 | 0.14 | Why? |
| Pain, Postoperative | 1 | 2017 | 289 | 0.13 | Why? |
| Anaphylaxis | 1 | 2021 | 940 | 0.11 | Why? |
| Pulmonary Disease, Chronic Obstructive | 2 | 2020 | 3832 | 0.11 | Why? |
| Respiration Disorders | 1 | 2017 | 526 | 0.11 | Why? |
| Allergens | 1 | 2017 | 728 | 0.11 | Why? |
| Polymorphism, Genetic | 1 | 2017 | 1074 | 0.10 | Why? |
| Allergists | 2 | 2021 | 266 | 0.10 | Why? |
| Immunomodulation | 1 | 2017 | 1472 | 0.09 | Why? |
| Visual Analog Scale | 2 | 2019 | 151 | 0.09 | Why? |
| Diet | 1 | 2020 | 2052 | 0.09 | Why? |
| Smartphone | 1 | 2019 | 1840 | 0.09 | Why? |
| Critical Pathways | 1 | 2017 | 1587 | 0.08 | Why? |
| Polymorphism, Single Nucleotide | 2 | 2017 | 3607 | 0.08 | Why? |
| Mobile Applications | 2 | 2019 | 3032 | 0.08 | Why? |
| Delivery of Health Care, Integrated | 1 | 2017 | 1549 | 0.07 | Why? |
| Genetic Predisposition to Disease | 2 | 2017 | 4027 | 0.07 | Why? |
| Biological Products | 1 | 2017 | 2331 | 0.06 | Why? |
| Brassica | 1 | 2021 | 66 | 0.05 | Why? |
| Antioxidants | 2 | 2021 | 1593 | 0.05 | Why? |
| Fermentation | 1 | 2020 | 156 | 0.05 | Why? |
| Humans | 22 | 2021 | 930598 | 0.05 | Why? |
| Disease Models, Animal | 1 | 2017 | 10998 | 0.05 | Why? |
| Epinephrine | 1 | 2021 | 323 | 0.05 | Why? |
| Dental Pulp Cavity | 1 | 2017 | 16 | 0.05 | Why? |
| Disease Resistance | 1 | 2020 | 236 | 0.05 | Why? |
| Information Technology | 1 | 2021 | 278 | 0.04 | Why? |
| Child | 5 | 2019 | 70012 | 0.04 | Why? |
| Vegetables | 1 | 2020 | 340 | 0.04 | Why? |
| Clinical Trials as Topic | 1 | 2017 | 7330 | 0.04 | Why? |
| Practice Guidelines as Topic | 2 | 2019 | 15421 | 0.04 | Why? |
| Pyrophosphatases | 1 | 2017 | 39 | 0.04 | Why? |
| Pandemics | 3 | 2021 | 389249 | 0.04 | Why? |
| Therapeutic Irrigation | 1 | 2017 | 167 | 0.04 | Why? |
| Th2 Cells | 1 | 2020 | 680 | 0.04 | Why? |
| Sodium Chloride | 1 | 2017 | 203 | 0.04 | Why? |
| Administration, Intranasal | 1 | 2020 | 1132 | 0.04 | Why? |
| Skin Tests | 1 | 2017 | 229 | 0.04 | Why? |
| Rhinitis, Allergic, Seasonal | 1 | 2017 | 121 | 0.04 | Why? |
| Efficiency | 1 | 2019 | 420 | 0.04 | Why? |
| Interleukin-13 | 1 | 2017 | 204 | 0.04 | Why? |
| Desensitization, Immunologic | 1 | 2021 | 574 | 0.04 | Why? |
| Global Health | 1 | 2019 | 13911 | 0.04 | Why? |
| Reactive Oxygen Species | 1 | 2020 | 1136 | 0.03 | Why? |
| Down-Regulation | 1 | 2021 | 1416 | 0.03 | Why? |
| Barbados | 1 | 2013 | 5 | 0.03 | Why? |
| Anti-Asthmatic Agents | 1 | 2019 | 427 | 0.03 | Why? |
| World Health Organization | 2 | 2017 | 4213 | 0.03 | Why? |
| Jamaica | 1 | 2013 | 47 | 0.03 | Why? |
| Eosinophils | 1 | 2020 | 848 | 0.03 | Why? |
| Haplotypes | 1 | 2017 | 853 | 0.03 | Why? |
| Administration, Inhalation | 1 | 2019 | 1647 | 0.03 | Why? |
| Up-Regulation | 1 | 2021 | 2249 | 0.03 | Why? |
| Gene Frequency | 1 | 2017 | 1210 | 0.03 | Why? |
| District of Columbia | 1 | 2013 | 343 | 0.03 | Why? |
| Europe | 2 | 2019 | 12702 | 0.03 | Why? |
| Evidence-Based Practice | 1 | 2017 | 693 | 0.03 | Why? |
| Infection Control | 1 | 2020 | 23131 | 0.03 | Why? |
| Latin America | 1 | 2017 | 1721 | 0.03 | Why? |
| Animals | 2 | 2017 | 78931 | 0.03 | Why? |
| Treatment Outcome | 1 | 2018 | 51732 | 0.03 | Why? |
| Alleles | 1 | 2017 | 1557 | 0.03 | Why? |
| Interleukin-10 | 1 | 2017 | 1409 | 0.03 | Why? |
| Oxidative Stress | 1 | 2021 | 2050 | 0.02 | Why? |
| Decision Support Techniques | 1 | 2017 | 903 | 0.02 | Why? |
| Randomized Controlled Trials as Topic | 2 | 2019 | 10649 | 0.02 | Why? |
| Early Diagnosis | 1 | 2017 | 2443 | 0.02 | Why? |
| Colombia | 1 | 2013 | 1241 | 0.02 | Why? |
| Phenotype | 1 | 2019 | 4037 | 0.02 | Why? |
| Monitoring, Physiologic | 1 | 2019 | 1956 | 0.02 | Why? |
| Telemedicine | 1 | 2019 | 25032 | 0.02 | Why? |
| Brazil | 2 | 2017 | 12582 | 0.02 | Why? |
| Molecular Epidemiology | 1 | 2013 | 1638 | 0.02 | Why? |
| Patient Care Team | 1 | 2021 | 3556 | 0.02 | Why? |
| Turkey | 1 | 2017 | 3937 | 0.02 | Why? |
| Case-Control Studies | 2 | 2017 | 17671 | 0.02 | Why? |
| Odds Ratio | 1 | 2017 | 5861 | 0.02 | Why? |
| New York | 1 | 2013 | 2488 | 0.02 | Why? |
| Symptom Assessment | 1 | 2019 | 4967 | 0.02 | Why? |
| Genotype | 1 | 2017 | 4697 | 0.02 | Why? |
| Signal Transduction | 1 | 2020 | 7207 | 0.02 | Why? |
| Child, Preschool | 2 | 2019 | 36283 | 0.02 | Why? |
| Risk Factors | 3 | 2019 | 71621 | 0.02 | Why? |
| Clinical Decision-Making | 1 | 2017 | 3755 | 0.02 | Why? |
| CD8-Positive T-Lymphocytes | 1 | 2020 | 5837 | 0.02 | Why? |
| Immunoglobulin M | 1 | 2020 | 9091 | 0.02 | Why? |
| Pneumonia, Viral | 2 | 2020 | 243684 | 0.01 | Why? |
| Triage | 1 | 2021 | 7151 | 0.01 | Why? |
| Coronavirus Infections | 2 | 2020 | 253789 | 0.01 | Why? |
| Disease Management | 1 | 2019 | 6841 | 0.01 | Why? |
| Male | 5 | 2021 | 367725 | 0.01 | Why? |
| Aging | 1 | 2017 | 3581 | 0.01 | Why? |
| Sex Factors | 1 | 2017 | 11014 | 0.01 | Why? |
| Adolescent | 2 | 2019 | 86841 | 0.01 | Why? |
| Antibodies, Monoclonal | 1 | 2017 | 8041 | 0.01 | Why? |
| African Americans | 1 | 2013 | 3363 | 0.01 | Why? |
| Infant, Newborn | 1 | 2019 | 23105 | 0.01 | Why? |
| Biomarkers | 1 | 2021 | 23361 | 0.01 | Why? |
| Adult | 3 | 2019 | 244371 | 0.01 | Why? |
| Female | 4 | 2019 | 380317 | 0.01 | Why? |
| Quality of Life | 1 | 2017 | 9820 | 0.01 | Why? |
| Infant | 1 | 2019 | 30274 | 0.01 | Why? |
| Betacoronavirus | 1 | 2020 | 204454 | 0.01 | Why? |
| Algorithms | 1 | 2013 | 7346 | 0.01 | Why? |
| Models, Statistical | 1 | 2013 | 5312 | 0.01 | Why? |
| Aged | 2 | 2021 | 215776 | 0.01 | Why? |
| Delivery of Health Care | 1 | 2019 | 15909 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2021 | 48226 | 0.01 | Why? |
| Prospective Studies | 1 | 2017 | 43301 | 0.01 | Why? |
| Health Personnel | 1 | 2021 | 29646 | 0.01 | Why? |
| Middle Aged | 2 | 2019 | 270681 | 0.01 | Why? |
| Aged, 80 and over | 1 | 2019 | 88759 | 0.01 | Why? |
| Young Adult | 1 | 2019 | 93724 | 0.01 | Why? |
Cruz's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(138)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(283)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_